American Century Companies’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Buy |
+89,937
| New | +$327K | ﹤0.01% | 2642 |
|
|
2021
Q1 | – | Sell |
-142,482
| Closed | -$399K | – | 2197 |
|
|
2020
Q4 | $399K | Buy |
142,482
+107,970
| +313% | +$302K | ﹤0.01% | 1641 |
|
|
2020
Q3 | $87K | Buy |
34,512
+12,184
| +55% | +$30.7K | ﹤0.01% | 1772 |
|
|
2020
Q2 | $303K | Sell |
22,328
-55,633
| -71% | -$755K | ﹤0.01% | 1448 |
|
|
2020
Q1 | $591K | Buy |
+77,961
| New | +$591K | ﹤0.01% | 1127 |
|
|
2019
Q2 | – | Sell |
-180,482
| Closed | -$1.48M | – | 1264 |
|
|
2019
Q1 | $1.48M | Buy |
+180,482
| New | +$1.48M | ﹤0.01% | 1024 |
|
|
2018
Q3 | – | Sell |
-344,447
| Closed | -$3.44M | – | 1255 |
|
|
2018
Q2 | $3.44M | Sell |
344,447
-156,524
| -31% | -$1.56M | ﹤0.01% | 918 |
|
|
2018
Q1 | $4.77M | Buy |
500,971
+147,860
| +42% | +$1.41M | ﹤0.01% | 844 |
|
|
2017
Q4 | $5.25M | Buy |
353,111
+137,567
| +64% | +$2.05M | 0.01% | 838 |
|
|
2017
Q3 | $4.24M | Buy |
215,544
+122,924
| +133% | +$2.42M | ﹤0.01% | 892 |
|
|
2017
Q2 | $1.33M | Buy |
+92,620
| New | +$1.33M | ﹤0.01% | 1099 |
|